BioCryst Pharmaceuticals Stock Target Price and Analyst Consensus
| BCRX Stock | USD 7.60 0.11 1.47% |
The current analyst and expert consensus on BioCryst Pharmaceuticals is Strong Buy with 6 buy recommendations. The current projected BioCryst Pharmaceuticals target price consensus is 15.20, with 11 analyst opinions. BioCryst Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected BioCryst Pharmaceuticals target price to derive its highest and lowest estimates based on target price estimated volatility of 3.1615. Check out Macroaxis Advice on BioCryst Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy BioCryst Stock please use our How to Invest in BioCryst Pharmaceuticals guide.
Lowest Forecast 13.83 | Highest Forecast 16.87 | Target Price 15.2 |
BioCryst |
It's important to approach BioCryst Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize BioCryst Pharmaceuticals price targets
BioCryst Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using BioCryst Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at BioCryst Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if BioCryst Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional BioCryst Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of BioCryst Pharmaceuticals is a key component of BioCryst Pharmaceuticals valuation and have some predictive power on the future returns of a BioCryst Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Gambling Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Investor Favorites Invested over 60 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
 | Artificial Intelligence Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Manufacturing Invested over 30 shares | |
 | Business Services Invested few shares | |
 | Chemicals Invested over 30 shares | |
 | Momentum Invested few shares |
Additional Tools for BioCryst Stock Analysis
When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.